Test
NC1246632 RANDOM HEXAMERS 100UG
This is a class I (Kb)-restricted peptide epitope of OVA, an octameric peptide from ovalbumin presented by the class I MHC molecule, H-2Kb.
50-238-7078 ISOTOPICALLY LABELED DESTHIOBI
WuXi TIDES Fmoc-D-Phe(3,4-DiCl)-OH, 177966-58-4 | (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,4-dichlorophenyl)propanoic acid | ClC=1C=CC(=CC1Cl)C[C@H](C(O)=O)NC(OCC2C3=CC=CC=C3C4=CC=CC=C42)=O | M.F. C24H19Cl2NO4, M.W. 456.32
GMP APC/Fire™ 750 anti-human CD5 [L17F12]; Isotype: Mouse IgG2a, κ; Reactivity: Human; Apps: FC; Size: 100 tests
WuXi TIDES Fmoc-D-Phe(3,4-DiCl)-OH, 177966-58-4 | (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,4-dichlorophenyl)propanoic acid | ClC=1C=CC(=CC1Cl)C[C@H](C(O)=O)NC(OCC2C3=CC=CC=C3C4=CC=CC=C42)=O | M.F. C24H19Cl2NO4, M.W. 456.32
WuXi TIDES Fmoc-D-Phe(3,4-DiCl)-OH, 177966-58-4 | (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,4-dichlorophenyl)propanoic acid | ClC=1C=CC(=CC1Cl)C[C@H](C(O)=O)NC(OCC2C3=CC=CC=C3C4=CC=CC=C42)=O | M.F. C24H19Cl2NO4, M.W. 456.32
WuXi TIDES Fmoc-L-Phe(3,5-DiCl)-OH, 1260605-95-5 | (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,5-dichlorophenyl)propanoic acid | O=C(N[C@@H](CC1=CC(Cl)=CC(Cl)=C1)C(=O)O)OCC2C3=CC=CC=C3C4=C2C=CC=C4 | M.F. C24H19Cl2NO4, M.W. 456.32
(D-Ala2)-Gastric Inhibitory Polypeptide (human) Trifluoroacetate, H-Tyr-D-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln-OH, 444073-04-5, C226H338N60O66S, Mr 4983.53, 0.5mg. (D-Ala2)-GIP (human), [DAla2] Gastric Inhibitory Peptide (GIP), human. GIP receptor agonist.
Gastric Inhibitory Peptide (GIP), human - 1mg , Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln-OH Category/Application: Neuropeptides Hormones This item is non returnable
The MODified Histone Peptide Array is a valuable research tool that can be used to screen antibodies, enzymes and proteins for cross-reactivity or binding interactions with histones and their post-translational modifications. The MODified Histone Peptide Arrays screen 59 acetylation, methylation, phosphorylation, and citrullination modifications on the N-terminal tails of histones H2A, H2B, H3 and H4. Each peptide array contains 384 unique histone modification combinations in duplicate, including up to four separate modifications on the same 19mer peptide. This extensive coverage of histone modifications enables the study not only of individual sites, but also the effects of neighboring modifications on recognition and binding. The simple array protocol works like a Western blot; no special equipment needed.
(D-Arg1,D-Trp7·9,Leu11)-Substance P, H-D-Arg-Pro-Lys-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2, 91224-37-2, C75H108N20O13, Mr 1497.81, 1mg. Spantide I, [DArg1, DTrp7,9, Leu11] Substance P. Spantide I, a high potency substance P antagonist with a weak spasmogenic and a poor histamine releasing effect.
WuXi TIDES Fmoc-L-Phe(3,5-DiCl)-OH, 1260605-95-5 | (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,5-dichlorophenyl)propanoic acid | O=C(N[C@@H](CC1=CC(Cl)=CC(Cl)=C1)C(=O)O)OCC2C3=CC=CC=C3C4=C2C=CC=C4 | M.F. C24H19Cl2NO4, M.W. 456.32
WuXi TIDES Fmoc-D-Phe(3,4-DiCl)-OH, 177966-58-4 | (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,4-dichlorophenyl)propanoic acid | ClC=1C=CC(=CC1Cl)C[C@H](C(O)=O)NC(OCC2C3=CC=CC=C3C4=CC=CC=C42)=O | M.F. C24H19Cl2NO4, M.W. 456.32
Al @ 10 µg/mL, Mg @ 20 µg/mL Ca @ 32 µg/mL Cu, Fe, Pb, Zn @ 50 µg/mL B @ 1000 µg/mL, P @2000 µg/mL K @ 5000 µg/mL Na @10,000 µg/mL Matrix: 3% HNO3 (v/v) Volume: 500 mL